Financial Enhancement Group’s Express Scripts Holding Company ESRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-3,569
Closed -$235K 72
2017
Q1
$235K Sell
3,569
-13,512
-79% -$930K 0.11% 61
2016
Q4
$1.18M Buy
17,081
+177
+1% +$12.7K 0.61% 37
2016
Q3
$1.19M Sell
16,904
-57,754
-77% -$4.32M 0.65% 30
2016
Q2
$5.66M Buy
74,658
+1,901
+3% +$140K 3.47% 9
2016
Q1
$5M Buy
72,757
+2,536
+4% +$182K 3.26% 9
2015
Q4
$6.14M Buy
70,221
+1,843
+3% +$158K 3.76% 11
2015
Q3
$5.54M Buy
68,378
+2,581
+4% +$225K 3.65% 10
2015
Q2
$5.85M Buy
+65,797
New +$5.75M 3.68% 8

Other funds holding ESRX

Financial Enhancement Group's ESRX Position: Q2 2017 in Review

Financial Enhancement Group sold out of Express Scripts Holding Company (ESRX) in Q2 2017, closing a stake of 3,569 shares — an estimated $235K sold.

Financial Enhancement Group first reported a position in ESRX in Q2 2015 and held it in 8 quarters. The position peaked at $6.14M in Q4 2015. 1,046 funds tracked by Wall St. Rank hold ESRX as of Q2 2017.

  • Financial Enhancement Group reported no remaining Express Scripts Holding Company position as of Q2 2017 after selling out during the quarter.
  • Financial Enhancement Group sold 3,569 Express Scripts Holding Company shares in Q2 2017, an estimated $235K.
  • Financial Enhancement Group first reported a position in Express Scripts Holding Company in Q2 2015 and held it in 8 quarters.
  • Financial Enhancement Group's Express Scripts Holding Company position peaked at $6.14M in Q4 2015.
  • 1,046 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q2 2017.

Based on Financial Enhancement Group's 13F filing for Q2 2017, filed 14 Aug 2017.